News

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...
A 25-year-old athletic woman dies of a rare bone cancer less than a year after her condition of constant back pain was ...
Not much is known about this difficult disease sarcoma cancer because it is easy to ignore the small lumps in the beginning ...
Immy had just started driving lessons in January 2022, aged 17, when she began getting “shooting pains” in her left knee and thigh.
DelveInsight's "Uterine Sarcoma Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth ...
The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...
A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded ...
A soft tissue sarcoma (STS) is a malignant tumor that starts in soft tissue such as muscle, deep skin tissues, cartilage, or fat. It often occurs as a lump in the arm, although it can happen anywhere.
The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.